30618630|t|1, 25-D3 Protects From Cerebral Ischemia by Maintaining BBB Permeability via PPAR-gamma Activation.
30618630|a|The blood-brain barrier (BBB) is a physical and biochemical barrier that maintains cerebral homeostasis. BBB dysfunction in an ischemic stroke, results in brain injury and subsequent neurological impairment. The aim of this study was to determine the possible protective effects of 1, 25-dihydroxyvitamin D3 [1, 25(OH)2D3, 1, 25-D3, vit D] on BBB dysfunction, at the early stages of an acute ischemic brain injury. We analyzed the effects of 1, 25-D3 on BBB integrity in terms of histopathological changes, the neurological deficit, infarct size and the expression of brain derived neurotrophic factor (BDNF), in a middle cerebral artery occlusion/reperfusion (MCAO/R) rat model. BBB permeability and the expression of permeability-related proteins in the brain were also evaluated by Evans blue (EB) staining and Western blotting respectively. To determine the possible mechanism underlying the role of 1, 25-D3 in BBB maintenance, after MCAO/R, the rats were treated with the specific peroxisome proliferator-activated receptor gamma (PPARgamma) inhibitor GW9662. Supplementation with 1, 25-D3 markedly improved the neurological scores of the rats, decreased the infarct volume, prevented neuronal deformation and upregulated the expression of the tight junction (TJ) and BDNF proteins in their brains. Furthermore, it activated PPARgamma but downregulated neuro-inflammatory cytokines such as nuclear factor kappa-B (NF-kappaB) and tumor necrosis factor-alpha (TNF-alpha), after MCAO/R. Taken together, 1, 25-D3 protects against cerebral ischemia by maintaining BBB permeability, upregulating the level of BDNF and inhibiting PPARgamma-mediated neuro-inflammation.
30618630	0	8	1, 25-D3	Chemical	-
30618630	23	40	Cerebral Ischemia	Disease	MESH:D002545
30618630	77	87	PPAR-gamma	Gene	25664
30618630	205	220	BBB dysfunction	Disease	MESH:C536830
30618630	227	242	ischemic stroke	Disease	MESH:D002544
30618630	255	267	brain injury	Disease	MESH:D001930
30618630	283	306	neurological impairment	Disease	MESH:D009422
30618630	382	407	1, 25-dihydroxyvitamin D3	Chemical	MESH:D002117
30618630	409	421	1, 25(OH)2D3	Chemical	MESH:D002117
30618630	423	431	1, 25-D3	Chemical	-
30618630	433	438	vit D	Chemical	MESH:D014807
30618630	443	458	BBB dysfunction	Disease	MESH:C536830
30618630	492	513	ischemic brain injury	Disease	MESH:D001930
30618630	542	550	1, 25-D3	Chemical	-
30618630	611	631	neurological deficit	Disease	MESH:D009461
30618630	633	640	infarct	Disease	MESH:D007238
30618630	668	701	brain derived neurotrophic factor	Gene	24225
30618630	703	707	BDNF	Gene	24225
30618630	715	747	middle cerebral artery occlusion	Disease	MESH:D020244
30618630	761	765	MCAO	Disease	
30618630	769	772	rat	Species	10116
30618630	885	895	Evans blue	Chemical	MESH:D005070
30618630	897	899	EB	Chemical	MESH:D005070
30618630	1004	1012	1, 25-D3	Chemical	-
30618630	1039	1043	MCAO	Disease	
30618630	1051	1055	rats	Species	10116
30618630	1087	1135	peroxisome proliferator-activated receptor gamma	Gene	25664
30618630	1137	1146	PPARgamma	Gene	25664
30618630	1158	1164	GW9662	Chemical	MESH:C457499
30618630	1187	1195	1, 25-D3	Chemical	-
30618630	1245	1249	rats	Species	10116
30618630	1265	1272	infarct	Disease	MESH:D007238
30618630	1374	1378	BDNF	Gene	24225
30618630	1431	1440	PPARgamma	Gene	25664
30618630	1535	1562	tumor necrosis factor-alpha	Gene	24835
30618630	1564	1573	TNF-alpha	Gene	24835
30618630	1582	1586	MCAO	Disease	
30618630	1587	1589	R.	Disease	MESH:C580424
30618630	1606	1614	1, 25-D3	Chemical	-
30618630	1632	1649	cerebral ischemia	Disease	MESH:D002545
30618630	1709	1713	BDNF	Gene	24225
30618630	1729	1738	PPARgamma	Gene	25664
30618630	1748	1766	neuro-inflammation	Disease	MESH:D007249
30618630	Negative_Correlation	MESH:D002117	MESH:C536830
30618630	Association	MESH:D002545	24225
30618630	Association	MESH:D002545	25664
30618630	Association	MESH:D007249	25664
30618630	Negative_Correlation	MESH:C457499	25664
30618630	Negative_Correlation	MESH:D014807	MESH:C536830

